Back to results
US 6,673,986 B1Granted
Generation of xenogeneic antibodies
AssigneeAbgenix, Inc.
InventorsRaju Kucherlapati, Aya Jakobovits, Sue Klapholz, Daniel G. Brenner, Daniel J. Capon
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeAbgenix, Inc.
InventorsRaju Kucherlapati, Aya Jakobovits, Sue Klapholz, Daniel G. Brenner, Daniel J. Capon
Estimating the term…
The subject invention provides non-human mammalian hosts characterized by inactivated endogenous Ig loci and functional human Ig loci for response to an immunogen to produce human antibodies or analogs thereof. The hosts are produced by multiple genetic modifications of embryonic cells in conjunction with breeding. Different strategies are employed for recombination of the human loci randomly or at analogous host loci. Chimeric and transgenic mammals, particularly mice, are provided, having stably integrated large, xenogeneic DNA segments. The segments are introduced by fusion with yeast spheroplasts comprising yeast artificial chromosomes (YACs) which include the xenogeneic DNA segments and a selective marker such as HPRT, and embryonic stem cells.
A transgenic mouse comprising in its germline a modified genome wherein said modification comprises inactivated endogenous immunoglobulin heavy chain loci in which all of the J segment genes from both copies of the immunoglobulin heavy chain locus are deleted to prevent rearrangement and to prevent formation of a transcript of a rearranged locus and the expression of an endogenous immunoglobulin heavy chain from the inactivated loci.
Dependencies are inferred from the claim text.